On a per-share basis, the
The results missed
The biotechnology company posted revenue of
Momenta shares have increased 67% since the beginning of the year. The stock has nearly tripled in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a
Automated Insights, source